Brief: Entrada Therapeutics reports Q2 results
11/08/2022 12:36
Aug 11 (Reuters) - Entrada Therapeutics Inc TRDA.O :
* ENTRADA THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
* ENTRADA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.74
Source text for Eikon: ID:nGNX640h9Z
Further company coverage: TRDA.O
Recent news on Entrada Therapeutics
See all newsBrief: Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Entrada Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Entrada Therapeutics Q2 Collaboration Revenue USD 898 Thousand
Entrada Therapeutics Q2 net loss narrows on lower costs
Entrada Therapeutics Inc expected to post a loss of $1.05 a share - Earnings Preview